- Home
- SIGA vs KREF Comparison
SIGA vs KREF Comparison
Compare SIGA & KREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- KREF
- Stock Information
- Founded
- SIGA 1995
- KREF 2014
- Country
- SIGA United States
- KREF United States
- Employees
- SIGA N/A
- KREF N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- KREF Real Estate Investment Trusts
- Sector
- SIGA Health Care
- KREF Real Estate
- Exchange
- SIGA Nasdaq
- KREF Nasdaq
- Market Cap
- SIGA 515.1M
- KREF 606.8M
- IPO Year
- SIGA 1997
- KREF 2017
- Fundamental
- Price
- SIGA $9.13
- KREF $9.53
- Analyst Decision
- SIGA
- KREF Buy
- Analyst Count
- SIGA 0
- KREF 7
- Target Price
- SIGA N/A
- KREF $12.32
- AVG Volume (30 Days)
- SIGA 640.7K
- KREF 533.5K
- Earning Date
- SIGA 08-05-2025
- KREF 10-20-2025
- Dividend Yield
- SIGA 6.57%
- KREF 10.55%
- EPS Growth
- SIGA N/A
- KREF N/A
- EPS
- SIGA 1.14
- KREF N/A
- Revenue
- SIGA $179,639,422.00
- KREF $40,393,000.00
- Revenue This Year
- SIGA N/A
- KREF $27.61
- Revenue Next Year
- SIGA $95.31
- KREF N/A
- P/E Ratio
- SIGA $8.01
- KREF N/A
- Revenue Growth
- SIGA 3.86
- KREF N/A
- 52 Week Low
- SIGA $4.95
- KREF $8.28
- 52 Week High
- SIGA $9.80
- KREF $12.95
- Technical
- Relative Strength Index (RSI)
- SIGA 67.83
- KREF 59.50
- Support Level
- SIGA $8.39
- KREF $9.10
- Resistance Level
- SIGA $9.14
- KREF $9.38
- Average True Range (ATR)
- SIGA 0.50
- KREF 0.16
- MACD
- SIGA 0.04
- KREF 0.02
- Stochastic Oscillator
- SIGA 84.19
- KREF 98.17
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About KREF KKR Real Estate Finance Trust Inc.
KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.